PATENT CLAIM ANALYSIS

Application Number: 15902547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "249000"]

Abstract:
In one aspect, the invention relates to substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 1  (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 19):
The kit of  claim 18 , wherein the at least one compound and the at least one agent are co-formulated.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.56716
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14787722', '14354560', '14787717', '14913266', '13692969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8563953196734866
- 35 USC 102 Novelty (BERT): 0.5718831081410836
- Combined Prediction Score: 0.8279440985202463
- Mean Citation Score: 595.6632320000001
- Max Citation Score: 602.8802
- Similarity Product: 323.311213899219

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test